145 related articles for article (PubMed ID: 7478803)
1. Obesity after successful treatment of acute lymphoblastic leukemia in childhood.
Van Dongen-Melman JE; Hokken-Koelega AC; Hählen K; De Groot A; Tromp CG; Egeler RM
Pediatr Res; 1995 Jul; 38(1):86-90. PubMed ID: 7478803
[TBL] [Abstract][Full Text] [Related]
2. Influence of treatment modalities on body weight in acute lymphoblastic leukemia.
Groot-Loonen JJ; Otten BJ; van't Hof MA; Lippens RJ; Stoelinga GB
Med Pediatr Oncol; 1996 Aug; 27(2):92-7. PubMed ID: 8649326
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin.
Belgaumi AF; Al-Bakrah M; Al-Mahr M; Al-Jefri A; Al-Musa A; Saleh M; Salim MF; Osman M; Osman L; El-Solh H
Cancer; 2003 Jun; 97(11):2898-903. PubMed ID: 12767105
[TBL] [Abstract][Full Text] [Related]
4. Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
Hurwitz CA; Silverman LB; Schorin MA; Clavell LA; Dalton VK; Glick KM; Gelber RD; Sallan SE
Cancer; 2000 Apr; 88(8):1964-9. PubMed ID: 10760775
[TBL] [Abstract][Full Text] [Related]
5. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
[TBL] [Abstract][Full Text] [Related]
6. Bony morbidity in children treated for acute lymphoblastic leukemia.
Strauss AJ; Su JT; Dalton VM; Gelber RD; Sallan SE; Silverman LB
J Clin Oncol; 2001 Jun; 19(12):3066-72. PubMed ID: 11408503
[TBL] [Abstract][Full Text] [Related]
7. Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.
Razzouk BI; Rose SR; Hongeng S; Wallace D; Smeltzer MP; Zacher M; Pui CH; Hudson MM
J Clin Oncol; 2007 Apr; 25(10):1183-9. PubMed ID: 17401007
[TBL] [Abstract][Full Text] [Related]
8. [Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?].
Bélien-Pallet V; Cabrol S; Fasola S; Petit A; Landman-Parker J; Auvrignon A; Leverger G
Arch Pediatr; 2010 Dec; 17(12):1637-44. PubMed ID: 20943354
[TBL] [Abstract][Full Text] [Related]
9. Changes in body mass index in long-term survivors of childhood acute lymphoblastic leukemia treated without cranial radiation and with reduced glucocorticoid therapy.
Touyz LM; Cohen J; Neville KA; Wakefield CE; Garnett SP; Mallitt KA; Grech AM; Cohn RJ
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27862918
[TBL] [Abstract][Full Text] [Related]
10. Growth in children with acute lymphoblastic leukemia during treatment.
Collins L; Zarzabal LA; Nayiager T; Pollock BH; Barr RD
J Pediatr Hematol Oncol; 2010 Nov; 32(8):e304-7. PubMed ID: 20930651
[TBL] [Abstract][Full Text] [Related]
11. Obesity in long-term survivors of childhood acute lymphoblastic leukemia.
Asner S; Ammann RA; Ozsahin H; Beck-Popovic M; von der Weid NX
Pediatr Blood Cancer; 2008 Jul; 51(1):118-22. PubMed ID: 18338394
[TBL] [Abstract][Full Text] [Related]
12. Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia.
Petersen KB; Müller J; Rasmussen M; Schmiegelow K
Med Pediatr Oncol; 2003 Aug; 41(2):110-4. PubMed ID: 12825213
[TBL] [Abstract][Full Text] [Related]
13. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for the development of obesity in children surviving ALL and NHL.
Gofman I; Ducore J
J Pediatr Hematol Oncol; 2009 Feb; 31(2):101-7. PubMed ID: 19194192
[TBL] [Abstract][Full Text] [Related]
15. Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone.
Ularntinon S; Tzuang D; Dahl G; Shaw RJ
Pediatrics; 2010 May; 125(5):e1241-5. PubMed ID: 20385646
[TBL] [Abstract][Full Text] [Related]
16. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
17. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
[TBL] [Abstract][Full Text] [Related]
18. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia.
Chow EJ; Pihoker C; Hunt K; Wilkinson K; Friedman DL
Cancer; 2007 Nov; 110(10):2313-20. PubMed ID: 17896787
[TBL] [Abstract][Full Text] [Related]
19. Body composition in long-term survivors of childhood acute lymphoblastic leukemia (ALL).
van der Sluis IM; van den Heuvel MM; de Muinck Keizer-Schrama SM
Med Pediatr Oncol; 2003 Jun; 40(6):407. PubMed ID: 12692817
[No Abstract] [Full Text] [Related]
20. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
Mattano LA; Sather HN; Trigg ME; Nachman JB
J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
